In human HCC, MAT1A:MAT2A expression and MATI/III: MATII activity ratios correlate negatively with cell proliferation and genomic instability, and positively with apoptosis and DNA methylation, and MATI/III: MATII ratio strongly predicts patients’ survival length [99,104]. Here, MAT2A is linked to hepatocellular carcinoma.